Vol 8, Supplement 5 (December 31, 2019): Translational Andrology and Urology

Editorial Commentary

Enhanced power bacillus Calmette-Guérin—possibly too much of a good thing

Wojciech Krajewski, Sławomir Poletajew

PDF Pages: S461-S462 Full Text (710) Open Access

Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer—an evaluation of radical cystectomy versus trimodal therapy costs

Diana E. Magee, Girish S. Kulkarni

PDF Pages: S463-S465 Full Text (1106) Open Access

PD-L1 testing in urothelial carcinoma: are we there yet?

Geert J. L. H. van Leenders

PDF Pages: S466-S468 Full Text (820) Open Access

Enhancing response to immunotherapy in urothelial carcinoma by targeted inhibition of the histone methyltransferase G9a pathway

Denzel Zhu, Emily Barry, Alexander I. Sankin

PDF Pages: S469-S471 Full Text (946) Open Access

Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact

Leonardo O. Reis

PDF Pages: S472-S473 Full Text (720) Open Access

Preservation of the bladder, but at what cost?

Niklas Harland, Arnulf Stenzl

PDF Pages: S474-S475 Full Text (807) Open Access

Magnetic resonance imaging sequences for prostate cancer triage: two is a couple, three is a crowd?

Piet Dirix, Siska Van Bruwaene, Hendrik Vandeursen, Filip Deckers

PDF Pages: S476-S479 Full Text (734) Open Access

Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective

Giovanni Motterle, R. Jeffrey Karnes

PDF Pages: S480-S481 Full Text (806) Open Access

Risk stratification system for biparametric prostate magnetic resonance imaging

Eugenio Martorana, Pietro Scialpi, Riccardo Grisanti, Michele Scialpi

PDF Pages: S482-S483 Full Text (937) Open Access

A novel biparametric magnetic resonance imaging sequence provides a more efficient and similarly efficacious method of risk stratifying men clinically suspected of having prostate cancer

Megan Stout, Tasha Posid, Shawn Dason

PDF Pages: S484-S485 Full Text (1089) Open Access

Bladder cancer under staging: still unavoidable?

Angelo Naselli, Andrea Guarneri

PDF Pages: S486-S487 Full Text (831) Open Access

Holding a MIRror up to the robustness of the prostate cancer urinary transcriptome

Adele E. Connor, Asia C. Jordan, Antoinette S. Perry

PDF Pages: S488-S490 Full Text (979) Open Access

The inflammatory potential of diet and bladder cancer risk: results from a prospective cohort study

Christian Daniel Fankhauser, Hugh Mostafid

PDF Pages: S491-S492 Full Text (697) Open Access

Challenges of urine-based molecular assays for the detection of urothelial cancer

Joep J. de Jong, Kim E. M. van Kessel, Monique J. Roobol, Joost L. Boormans

PDF Pages: S493-S496 Full Text (766) Open Access

A new era in the detection of urothelial carcinoma by sequencing cell-free DNA

Yujiro Hayashi, Kazutoshi Fujita

PDF Pages: S497-S501 Full Text (1152) Open Access

Are we really seeking for equivalence?—The virtue of the robot is in technology

Aldo Brassetti, Riccardo Mastroianni, Giuseppe Simone

PDF Pages: S502-S504 Full Text (767) Open Access

High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool?

Marta Bottero, Emanuele Alì, Chiara Demofonti, Andrea Lancia, Riccardo Santoni, Cynthia Aristei, Gianluca Ingrosso

PDF Pages: S505-S506 Full Text (1037) Open Access

Patient decision aids for urinary diversion after radical cystectomy: their potential and pitfalls

Eva Browne, Jack Whooley, Jianwei Wang, Niall F. Davis

PDF Pages: S507-S509 Full Text (1177) Open Access

Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics

Joseph Y. Clark, Jay D. Raman

PDF Pages: S510-S513 Full Text (1684) Open Access

The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer

Neil B. Desai, Aditya Bagrodia

PDF Pages: S514-S516 Full Text (879) Open Access

Bacillus Calmette Guérin in bladder cancer: is more immune stimulation better?

Mar Valés-Gómez

PDF Pages: S517-S520 Full Text (895) Open Access

Robotic assisted radical cystectomy: insights on long term oncological outcomes from the International Robotic Cystectomy Consortium

Maria Chiara Sighinolfi, Salvatore Micali, Ahmed Eissa, Stefano Carlo Maria Picozzi, Stefano Puliatti, Bernardo Rocco

PDF Pages: S521-S523 Full Text (869) Open Access

Capturing recurrence in urothelial carcinoma: “more than meets the eye”

Aly-Khan A. Lalani, Sumanta K. Pal, Guru P. Sonpavde, Petros Grivas

PDF Pages: S524-S527 Full Text (731) Open Access

Hypofractionation in prostate cancer radiotherapy: a step forward towards clinical routine

Barbara Vischioni, Rachele Petrucci, Francesca Valvo

PDF Pages: S528-S532 Full Text (987) Open Access

The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer

Abhishek A. Solanki, Stanley L. Liauw

PDF Pages: S533-S537 Full Text (1053) Open Access

New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: is the era of melting glaciers upcoming?

Rosario Mazzola, Francesco Cuccia, Vanessa Figlia, Niccolò Giaj-Levra, Luca Nicosia, Francesco Ricchetti, Michele Rigo, Nadia Pasinetti, Matteo Salgarello, Filippo Alongi

PDF Pages: S538-S541 Full Text (1212) Open Access

Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States

Timothy N. Clinton, Michal Wiseman, Aleksandra Walasek, Eugene Pietzak

PDF Pages: S542-S545 Full Text (836) Open Access

UroSEEK gene panel for bladder cancer surveillance

Regan Wong, Charles J. Rosser

PDF Pages: S546-S549 Full Text (1199) Open Access

Letter to the Editor

Influence of auriculotherapy on erectile dysfunction: commentaries and perspectives

Matias Noll, Carolina Rodrigues de Mendonça, Priscilla Rayanne e Silva Noll, Erika Aparecida Silveira

PDF Pages: S550-S551 Full Text (849) Open Access

News

Application of the CARE guideline as reporting standard in the Translational Andrology and Urology

Editorial Office

PDF Pages: S552 Full Text (681) Open Access

Disclosure:

The supplement was published without any sponsorship or funding.